Current evidence shows that some dysregulation in PCOS, such as metabolic syndrome and insulin resistance, along with excessive activation of LH-secreting neuroendocrine circuits and accompanying chronic inflammation, are positively correlated with amyloid-beta aggregation. The gene discussed is PLOD1; the disease is metabolic syndrome.